BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35032130)

  • 21. Racemic synephrine found in Citrus aurantium-listing pre-workout supplements suggests a non-plant-based origin.
    Koh AHW; Chess-Williams R; Lohning AE
    Drug Test Anal; 2021 Aug; 13(8):1569-1575. PubMed ID: 33834625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bitter orange (
    Deshmukh NS; Stohs SJ; Magar CC; Kale A; Sowmya B
    Toxicol Rep; 2017; 4():598-613. PubMed ID: 29214145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects.
    Stohs SJ; Preuss HG; Shara M
    Oxid Med Cell Longev; 2011; 2011():482973. PubMed ID: 21904645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
    Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of CEDIA amphetamines assay after a single dose of bitter orange.
    Nguyen DT; Bui LT; Ambrose PJ
    Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium.
    Pellati F; Benvenuti S
    J Chromatogr A; 2007 Aug; 1161(1-2):71-88. PubMed ID: 17582424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements.
    Mercolini L; Mandrioli R; Trerè T; Bugamelli F; Ferranti A; Raggi MA
    J Sep Sci; 2010 Aug; 33(16):2520-7. PubMed ID: 20645392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection.
    Slezak T; Francis PS; Anastos N; Barnett NW
    Anal Chim Acta; 2007 Jun; 593(1):98-102. PubMed ID: 17531829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Safety and Efficacy of
    Koncz D; Tóth B; Bahar MA; Roza O; Csupor D
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of Bitter Orange alkaloids in dietary supplements standard reference materials by liquid chromatography with ultraviolet absorbance and fluorescence detection.
    Putzbach K; Rimmer CA; Sharpless KE; Sander LC
    J Chromatogr A; 2007 Jul; 1156(1-2):304-11. PubMed ID: 17524413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research.
    Fugh-Berman A; Myers A
    Exp Biol Med (Maywood); 2004 Sep; 229(8):698-704. PubMed ID: 15337824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental toxicity of Citrus aurantium in rats.
    Hansen DK; Juliar BE; White GE; Pellicore LS
    Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):216-23. PubMed ID: 21594979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of ephedra-free weight-loss supplements in humans.
    Haller CA; Benowitz NL; Jacob P
    Am J Med; 2005 Sep; 118(9):998-1003. PubMed ID: 16164886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytochemical compounds in sport nutrition: Synephrine and hydroxycitric acid (HCA) as examples for evaluation of possible health risks.
    Bakhiya N; Ziegenhagen R; Hirsch-Ernst KI; Dusemund B; Richter K; Schultrich K; Pevny S; Schäfer B; Lampen A
    Mol Nutr Food Res; 2017 Jun; 61(6):. PubMed ID: 28271601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separation of Synephrine Enantiomers in Citrus Fruits by a Reversed Phase HPLC after Chiral Precolumn Derivatization.
    Tanaka S; Sekiguchi M; Yamamoto A; Aizawa SI; Sato K; Taga A; Terashima H; Ishihara Y; Kodama S
    Anal Sci; 2019 Apr; 35(4):407-412. PubMed ID: 30555107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular toxicity of Citrus aurantium in exercised rats.
    Hansen DK; George NI; White GE; Abdel-Rahman A; Pellicore LS; Fabricant D
    Cardiovasc Toxicol; 2013 Sep; 13(3):208-19. PubMed ID: 23397375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity.
    Deshmukh NS; Stohs SJ; Magar CC; Kadam SB
    Regul Toxicol Pharmacol; 2017 Nov; 90():318-327. PubMed ID: 28966104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast hepatic biotransformation of p-synephrine and p-octopamine and implications for their oral intake.
    da Silva-Pereira JF; Bubna GA; Gonçalves Gde A; Bracht F; Peralta RM; Bracht A
    Food Funct; 2016 Mar; 7(3):1483-91. PubMed ID: 26883936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of furanocoumarins in Advantra Z® (Citrus aurantium, bitter orange) extracts.
    Stohs SJ; Miller H; Romano F
    J Diet Suppl; 2014 Sep; 11(3):288-93. PubMed ID: 25026202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure and heart rate effects following a single dose of bitter orange.
    Bui LT; Nguyen DT; Ambrose PJ
    Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.